Skip to main content

Table 3 Incidence of diarrhea after first- and second-line weekly irinotecan and capecitabine

From: Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients

 

Total

Grade I

Grade II

Grade III

Grade IV

  

Number (%)

Number (%)

Number (%)

Number (%)

First-line treatment

30 (57.7)

10 (33.3)

3 (10)

2 (6.7)

0 (0)

Second-line treatment

22 (42.3)

6 (27.3)

2 (9.1)

1 (4.5)

1 (4.5)